Literature DB >> 10368232

Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients.

T Onishi1, Y Ohishi, H Goto, M Suzuki, Y Miyazawa.   

Abstract

OBJECTIVE: To determine the clinicopathological characteristics of histologically defined papillary renal cell carcinoma (RCC) in relation to prognosis. PATIENTS AND METHODS: In total, 768 patients with RCC underwent nephrectomy at our university hospital between 1957 and 1995. RCC was classified into clear-cell carcinoma in 689 patients (89.7%, no follow-up in 14), chromophobe cell carcinoma in 36 (4.7%, no follow-up in two) and papillary RCC in 43 (5.6%, no follow-up in one). In the present study, the 42 patients with papillary RCC who underwent nephrectomy and were followed up were those in whom the clinicopathological features of the papillary RCC were assessed. Factors assessed were the presence or absence of foam-cell infiltration, occurrence of bleeding and/or necrosis, presence or absence of a pseudocapsule, mixed occurrence with clear-cell carcinoma, presence or absence of solid variants, cytoplasmic appearance (basophilic vs eosinophilic cells), stage, nuclear grade of malignancy, and angiographic appearance in relation to prognosis. The prognosis was also compared among patients with clear-cell, chromophobe cell and papillary RCC.
RESULTS: The prognosis was significantly better in patients with foam-cell infiltration (P=0.03), with a pseudocapsule (P=0.07), with no solid variants (P=0.001) and with basophilic cells (P<0.001). There were also significant differences in survival between patients with low-stage (1+2) and high-stage (3+4) disease (P=0.003), and among grades 1-3 (grade 1 vs 2, P=0.05; grade 1 vs 3, P<0.001, grade 2 vs 3, P=0.006). Furthermore, the prognosis in patients with papillary RCC was worse than in those with chromophobe cell carcinoma (P=0.02), but there was no significant difference in survival between patients with papillary RCC and those with clear-cell carcinoma.
CONCLUSION: The clinicopathological features (e.g. the presence or absence of foam cells, of a pseudocapsule and of solid variants, cytoplasmic appearance, and the stage and nuclear grade of malignancy) are important prognostic factors for patients with papillary RCC. Furthermore, the prognosis in patients with papillary RCC is similar to those with clear-cell carcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10368232     DOI: 10.1046/j.1464-410x.1999.00094.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

1.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

2.  The largest reported papillary renal cell carcinoma.

Authors:  P K Hegarty; D Rea; C Gulmann; M Aktar; M D Jeffers; J Thornhill
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

3.  Papillary renal cell carcinoma. Prognostic value of morphological subtypes in a clinicopathologic study of 43 cases.

Authors:  Yves Allory; Delphine Ouazana; Eric Boucher; Nicolas Thiounn; Annick Vieillefond
Journal:  Virchows Arch       Date:  2003-04-04       Impact factor: 4.064

4.  Magnetic resonance imaging of large chromophobe renal cell carcinomas.

Authors:  Kohei Sasaguri; Hiroyuki Irie; Noriyuki Kamochi; Takahiko Nakazono; Ken Yamaguchi; Jiro Uozumi; Sho Kudo
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

Review 5.  Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

Authors:  Theodore F Logan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

6.  Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.

Authors:  Takeo Kosaka; Shuji Mikami; Akira Miyajima; Eiji Kikuchi; Ken Nakagawa; Takashi Ohigashi; Jun Nakashima; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2008-03-07       Impact factor: 2.801

7.  Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types.

Authors:  Li Peng; Xiu Wu Bian; Di Kang Li; Chuan Xu; Guang Ming Wang; Qing You Xia; Qing Xiong
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

8.  Histological characterisation of small renal masses and incidence of silent renal masses.

Authors:  Sergio Almenar Medina; Ana Calatrava Fons
Journal:  Adv Urol       Date:  2008-11-04

9.  A case of both clear and papillary renal cell carcinomas in the left kidney.

Authors:  Jan Kawecki; Paweł Leśniak; Karol Wieczorek; Paweł Budziarz; Wiesław Duda; Ryszard Poloczek; Sławomir Dutkiewicz
Journal:  Cent European J Urol       Date:  2012-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.